Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PIGV - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Invitae Limb and Digital Malformations Panel Invitae United States | 356 | 177 |
|
Inherited Glycosylphosphatidylinositol Biosynthesis Defects (IGDs) Panel PreventionGenetics United States | 23 | 21 |
|
Congenital Limb Malformation Panel PreventionGenetics United States | 78 | 75 |
|
Invitae United States | 442 | 298 |
|
Invitae Congenital Disorders of Glycosylation Panel Invitae United States | 203 | 152 |
|
Early Infantile Epileptic Encephalopathy Panel PreventionGenetics United States | 144 | 124 |
|
Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 234 | 240 |
|
Limb Abnormalities and Reduction Defects Panel GeneDx United States | 24 | 76 |
|
Fulgent Genetics United States | 509 | 275 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Syndromic Disorders Athena Diagnostics Inc United States | 30 | 31 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics Inc United States | 233 | 234 |
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 143 | 135 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.